Khyzer B Aziz1, Angie C Jelin2,3, Amaris M Keiser1, Jay Schulkin4, Eric B Jelin5. 1. Division of Neonatology, Department of Pediatrics, Johns Hopkins Children's Center, Baltimore, MD, USA. 2. Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, USA. 3. Institute of Genomic Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA. 4. Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA. 5. Department of Pediatric Surgery, Johns Hopkins Children's Center, Baltimore, MD, USA.
Abstract
BACKGROUND: Congenital pulmonary airway malformation (CPAM) is the most common prenatally-diagnosed lung malformation. This lesion, classified as macrocystic or microcystic, can lead to significant fetal compromise. Management options include observation, maternal antenatal steroid administration, and fetal surgical intervention. Current evidence suggests that microcystic (but not macrocystic) lesions and those with a cyst volume ratio (CVR) >1.6 are responsive to steroid therapy. The objective of this study was to identify patterns of prenatal steroid administration for the management of CPAMs and to identify characteristics of CPAMs prompting steroid administration. METHODS: An 18-question survey was distributed to obstetricians from the Pregnancy-Related Care Research Network (PRCRN) and the North American Fetal Therapy Network (NAFTNet), from January to April 2019, to capture antenatal steroid prescribing patterns. RESULTS: Response rates were 28.3% (138/487) for PRCRN and 63.3% (19/30) for NAFTNet. Among PRCRN members, 16.8% administered prenatal steroids, with most (77.2%) doing so for both microcystic and macrocystic CPAMs; corresponding percentages for NAFTNet members were 90.9% and 52.6%. Two thirds (65.6%) of obstetricians who administer steroids do so for a CVR > 1.6, without evidence of mediastinal shift or hydrops fetalis. CONCLUSIONS: There is a lack of consensus among obstetricians as to the CPAM characteristics that should prompt administration of prenatal steroids. Many surveyed obstetricians do not use cyst type or CVR to guide decision-making regarding steroid therapy.
BACKGROUND:Congenital pulmonary airway malformation (CPAM) is the most common prenatally-diagnosed lung malformation. This lesion, classified as macrocystic or microcystic, can lead to significant fetal compromise. Management options include observation, maternal antenatal steroid administration, and fetal surgical intervention. Current evidence suggests that microcystic (but not macrocystic) lesions and those with a cyst volume ratio (CVR) >1.6 are responsive to steroid therapy. The objective of this study was to identify patterns of prenatal steroid administration for the management of CPAMs and to identify characteristics of CPAMs prompting steroid administration. METHODS: An 18-question survey was distributed to obstetricians from the Pregnancy-Related Care Research Network (PRCRN) and the North American Fetal Therapy Network (NAFTNet), from January to April 2019, to capture antenatal steroid prescribing patterns. RESULTS: Response rates were 28.3% (138/487) for PRCRN and 63.3% (19/30) for NAFTNet. Among PRCRN members, 16.8% administered prenatal steroids, with most (77.2%) doing so for both microcystic and macrocystic CPAMs; corresponding percentages for NAFTNet members were 90.9% and 52.6%. Two thirds (65.6%) of obstetricians who administer steroids do so for a CVR > 1.6, without evidence of mediastinal shift or hydrops fetalis. CONCLUSIONS: There is a lack of consensus among obstetricians as to the CPAM characteristics that should prompt administration of prenatal steroids. Many surveyed obstetricians do not use cyst type or CVR to guide decision-making regarding steroid therapy.
Authors: S C Derderian; A M Coleman; C Jeanty; F Y Lim; A M Shaaban; J A Farrell; S Hirose; T C MacKenzie; H Lee Journal: J Pediatr Surg Date: 2014-10-01 Impact factor: 2.545
Authors: Timothy M Crombleholme; Beverly Coleman; Holly Hedrick; Kenneth Liechty; Lori Howell; Alan W Flake; Mark Johnson; N Scott Adzick Journal: J Pediatr Surg Date: 2002-03 Impact factor: 2.545
Authors: N S Adzick; M R Harrison; P L Glick; M S Golbus; R L Anderson; B S Mahony; P W Callen; J H Hirsch; D A Luthy; R A Filly Journal: J Pediatr Surg Date: 1985-10 Impact factor: 2.545
Authors: KuoJen Tsao; Samuel Hawgood; Lan Vu; Shinjiro Hirose; Roman Sydorak; Craig T Albanese; Diana L Farmer; Michael R Harrison; Hanmin Lee Journal: J Pediatr Surg Date: 2003-03 Impact factor: 2.545
Authors: Jason G Bunn; Jeanelle Sheeder; Jay Schulkin; Sindi Diko; Miriam Estin; Kathleen A Connell; K Joseph Hurt Journal: Int Urogynecol J Date: 2022-02-03 Impact factor: 1.932
Authors: Dandan Liu; Gang Zhang; Jianyi Liao; Lan Jiang; Chun Cai; Xiao Li; Lei Lou; Bin Zhou; Huiyi Zeng; Xiangang Yan; Gang Yu Journal: Comput Intell Neurosci Date: 2022-08-18